About Blackstone Life Sciences
Blackstone Life Sciences (BXLS) operates in the biotechnology sector, focusing on investments in advanced healthcare technologies to improve patient outcomes. The firm invests in both early and late-stage biotechnology and healthcare companies, particularly in therapeutics. BXLS collaborates with pharmaceutical, biotech, and medical technology companies to aim to address unmet medical needs that have the potential to improve the quality of life for patients around the world.
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Finance, AI/ML, Healthcare (+3 more)
Investor Type
Private Equity Firm
Investment Focus
Focus Areas
Investment Stages